NEKTAR THERAPEUTICS (NKTR)

US6402681083 - Common Stock

0.9005  -0.03 (-2.99%)

After market: 0.9008 +0 (+0.03%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
101.9M
-33.36%
92.1M
-9.62%
90.122M
-2.15%
101.7M
12.85%
90.11M
-11.40%
89.692M
-0.46%
121.96M
35.98%
189.37M
55.27%
95.31M
-49.67%
113.3M
18.88%
197.99M
74.75%
EBITDA
YoY % growth
-432M
-18.13%
-227.3M
47.38%
-127.41M
43.95%
-151.536M
-18.94%
-157.288M
-3.80%
-175.006M
-11.26%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-446.1M
-17.43%
-240.3M
46.13%
-135.225M
43.73%
-151.175M
-11.79%
-164.924M
-9.09%
-188.462M
-14.27%
-210.161M
-11.51%
-185.552M
11.71%
-271.268M
-46.20%
-170.618M
37.10%
-82.15M
51.85%
Operating Margin
-437.78%-260.91%-150.05%-148.65%-183.02%-210.12%-172.32%-97.98%-284.62%-150.59%-41.49%
EPS
YoY % growth
-2.85
-27.23%
-1.97
30.88%
-1.05
46.70%
-0.77
26.35%
-0.79
-2.42%
-0.72
9.71%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth
-0.17
24.76%
-0.21
-10.13%
-0.20
20.26%
-0.21
-15.92%
-0.21
-27.35%
-0.22
-7.24%
-0.23
-15.13%
-0.24
-14.88%
-0.23
-11.29%
-0.22-0.22
2.22%
-0.22
6.38%
Revenue
Q2Q % growth
30.504M
27.71%
24.44M
12.94%
25.054M
6.66%
25.233M
4.60%
27.716M
-9.14%
24.633M
0.79%
24.852M
-0.81%
25.214M
-0.08%
25.592M
-7.66%
17.34M
-29.61%
17.34M
-30.23%
17.34M
-31.23%
EBITDA
Q2Q % growth
-36.72M
-60.74%
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-31.975M
-4.29%
-38.29M
-11.14%
-39.097M
-7.16%
-39.297M
-14.57%
-39.618M
-23.90%
-45.049M
-17.65%
-48.453M
-23.93%
-52.078M
-32.53%
-57.812M
-45.92%
N/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.18
25.00%
-0.220.0416.31%
Q2 2024
Q2Q % growth
-0.25
7.41%
-0.21-0.04-20.38%
Q1 2024
Q2Q % growth
-0.19
40.63%
-0.190.001.96%
Q4 2023
Q2Q % growth
-0.22
31.25%
-0.220.00-1.55%
Q3 2023
Q2Q % growth
-0.24
22.58%
-0.20-0.04-17.98%
Q2 2023
Q2Q % growth
-0.27
68.24%
-0.290.026.75%
Q1 2023
Q2Q % growth
-0.32
34.69%
-0.26-0.06-24.21%
Q4 2022
Q2Q % growth
-0.32
59.49%
-0.460.1430.65%
Q3 2022
Q2Q % growth
-0.31
55.71%
-0.460.1532.39%
Q2 2022
Q2Q % growth
-0.85
-23.19%
-0.950.1010.99%
Q1 2022
Q2Q % growth
-0.49
26.87%
-0.690.2029.07%
Q4 2021
Q2Q % growth
-0.79
-21.54%
-0.830.044.31%
Q3 2021
Q2Q % growth
-0.70
-14.75%
-0.810.1114.04%
Q2 2021
Q2Q % growth
-0.69
-53.33%
-0.750.067.44%
Q1 2021
Q2Q % growth
-0.67
-26.42%
-0.740.079.02%
Q4 2020
Q2Q % growth
-0.65
-1.56%
-0.690.046.27%
Q3 2020
Q2Q % growth
-0.61
-8.93%
-0.750.1419.14%
Q2 2020
Q2Q % growth
-0.45
28.57%
-0.700.2535.53%
Q1 2020
Q2Q % growth
-0.53
22.06%
-0.790.2632.63%
Q4 2019
Q2Q % growth
-0.64
-12.28%
-0.690.057.83%
Q3 2019
Q2Q % growth
-0.56 -0.740.1824.43%
Q2 2019
Q2Q % growth
-0.63
-111.82%
-0.810.1822.50%
Q1 2019
Q2Q % growth
-0.68
-13.33%
-0.700.023.13%
Q4 2018
Q2Q % growth
-0.57 -0.670.1014.40%
Q3 2018
Q2Q % growth
-0.56 -0.640.0812.68%
Q2 2018
Q2Q % growth
5.33 5.330.000.07%
Q1 2018
Q2Q % growth
-0.60 -0.55-0.05-8.13%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
24.124M
-0.08%
18.646M5.478M29.38%
Q2 2024
Q2Q % growth
23.489M
14.59%
17.896M5.593M31.25%
Q1 2024
Q2Q % growth
21.639M
0.21%
15.649M5.99M38.28%
Q4 2023
Q2Q % growth
23.885M
8.57%
18.416M5.469M29.70%
Q3 2023
Q2Q % growth
24.144M
2.31%
21.739M2.405M11.06%
Q2 2023
Q2Q % growth
20.499M
-5.10%
22.263M-1.764M-7.92%
Q1 2023
Q2Q % growth
21.594M
-12.93%
20.235M1.359M6.72%
Q4 2022
Q2Q % growth
22M
-12.00%
22.576M-576K-2.55%
Q3 2022
Q2Q % growth
23.6M
-5.22%
23.061M539K2.34%
Q2 2022
Q2Q % growth
21.6M
-23.67%
23.118M-1.518M-6.57%
Q1 2022
Q2Q % growth
24.8M
5.08%
24.865M-65K-0.26%
Q4 2021
Q2Q % growth
25M
6.38%
25.84M-840K-3.25%
Q3 2021
Q2Q % growth
24.9M
-17.00%
28.425M-3.525M-12.40%
Q2 2021
Q2Q % growth
28.3M
-42.01%
26.5M1.8M6.79%
Q1 2021
Q2Q % growth
23.6M
-53.36%
27.442M-3.842M-14.00%
Q4 2020
Q2Q % growth
23.5M
-30.68%
30.615M-7.115M-23.24%
Q3 2020
Q2Q % growth
30M
2.74%
26.859M3.141M11.69%
Q2 2020
Q2Q % growth
48.8M
109.44%
23.255M25.545M109.85%
Q1 2020
Q2Q % growth
50.6M
79.43%
48.595M2.005M4.13%
Q4 2019
Q2Q % growth
33.9M
-14.82%
27.468M6.432M23.42%
Q3 2019
Q2Q % growth
29.2M
5.04%
26.924M2.276M8.45%
Q2 2019
Q2Q % growth
23.3M
-97.86%
27.186M-3.886M-14.29%
Q1 2019
Q2Q % growth
28.2M
-25.79%
28.188M12K0.04%
Q4 2018
Q2Q % growth
39.8M 26.542M13.258M49.95%
Q3 2018
Q2Q % growth
27.8M 26.605M1.195M4.49%
Q2 2018
Q2Q % growth
1.088B 1.054B33.7M3.20%
Q1 2018
Q2Q % growth
38M 36.328M1.672M4.60%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 25.62% 7.99% 8.83%
Revenue0% 72.1% 17.81% 28.9%